Le Lézard
Classified in: Transportation, Health
Subject: PDT

Envirotainer Opens RAP e2 Station in Liège (LGG)


UPPLANDS VÄSBY, Sweden, Oct. 17, 2019 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that they are upgrading their network of stations supporting their state-of-the-art e-technology container, the RAP e2, by adding Liège (LGG).

"Europe is the #1 pharmaceutical region in the world, with exports exceeding ?100 billion in 2017. Being the market leader in cold-chain solutions we subsequently have a very strong presence here since many years. The strongest reason for upgrading our Liège (LGG) station to also handle our RAP e2, even though we already have 15 RAP e2 stations in Europe, is purely based on customer needs. We wanted to create a significantly better customer experience for our pharmaceutical customers by reducing the need for trucking units between stations," said Niklas Lönnkvist, Head of Sales EMEA. He continues, "It's great to know that we both have the financial muscles as well as the willingness to go the extra mile to help our customers."

The RAP e2 is an extremely cost efficient and high performing solution compared to other active and passive alternatives. Envirotainer's RAP e2 container has proven its robustness since its inception and has to date shipped over 150,000 pallets with 0.00% product loss.

Liège (LGG) is the 34th station in the Envirotainer network to carry the RAP e2 solution, one of the most advanced temperature-controlled air cargo containers available.

Contact information:
Niklas Lönnkvist
Head of Sales EMEA
Envirotainer
+46-8-586-293-27
[email protected]

Mattias Isaksson
Head of Marketing & Communications
Envirotainer
[email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/envirotainer-ab/r/envirotainer-opens-rap-e2-station-in-liege--lgg-,c2933807

The following files are available for download:

https://mb.cision.com/Main/8981/2933807/1124570.pdf

Release

SOURCE Envirotainer AB


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: